BIO 2026: AI, federal policy impacts, and general vibes

The BIO 2026 conference, held in San Diego, generated a notably positive "vibe" among attendees, contrasting with less optimistic moods at other major industry events in the previous year. STAT's team, including biotech correspondent Meghana Keshavan, health tech reporter Brittany Trang, and Washington correspondent Daniel Payne, observed this shift in sentiment. Industry executives present at the conference also commented on the improved atmosphere. The event, likened to the "World Cup" of biotech, saw delegations from numerous countries, highlighting its global significance. The discussions at BIO 2026 encompassed the impacts of artificial intelligence on the sector and the evolving landscape of federal policy, alongside general industry outlooks. This year's conference marked a significant departure from the perceived negativity of prior industry gatherings, suggesting a renewed sense of optimism within the biotechnology field.